Table 5.
Antibiotic | TNo. | Heavy metal | |||||||
---|---|---|---|---|---|---|---|---|---|
Cd | Cr | Cu | Hg | ||||||
No. | % | No. | % | No. | % | No. | % | ||
AML | 39 | 38 | 97.4 | 39 | 100 | 33 | 84.6 | 39 | 100 |
AMP | 31 | 30 | 96.8 | 31 | 100 | 25 | 80.6 | 31 | 100 |
K | 4 | 3 | 75 | 4 | 100 | 1 | 25 | 4 | 100 |
NV | 35 | 35 | 100 | 35 | 100 | 32 | 91.4 | 35 | 100 |
MY | 71 | 65 | 91.5 | 71 | 100 | 56 | 78.9 | 71 | 100 |
E | 39 | 37 | 94.9 | 39 | 100 | 35 | 89.7 | 39 | 100 |
OL | 56 | 54 | 96.4 | 56 | 100 | 49 | 87.5 | 56 | 100 |
SP | 31 | 31 | 100 | 31 | 100 | 29 | 93.5 | 31 | 100 |
NA | 5 | 5 | 100 | 5 | 100 | 5 | 100 | 5 | 100 |
OA | 7 | 7 | 100 | 7 | 100 | 6 | 85.7 | 7 | 100 |
UB | 5 | 5 | 100 | 5 | 100 | 5 | 100 | 5 | 100 |
RL | 26 | 24 | 92.3 | 26 | 100 | 21 | 80.8 | 26 | 100 |
DO | 6 | 6 | 100 | 6 | 100 | 6 | 100 | 6 | 100 |
OT | 11 | 11 | 100 | 11 | 100 | 8 | 72.7 | 11 | 100 |
TE | 7 | 6 | 85.7 | 7 | 100 | 5 | 71.4 | 7 | 100 |
C | 2 | 2 | 100 | 2 | 100 | 2 | 100 | 2 | 100 |
FFC | 2 | 2 | 100 | 2 | 100 | 2 | 100 | 2 | 100 |
F | 16 | 16 | 100 | 16 | 100 | 13 | 81.3 | 16 | 100 |
FR | 55 | 53 | 96.4 | 55 | 100 | 46 | 83.6 | 55 | 100 |
FOS | 21 | 20 | 95.2 | 21 | 100 | 18 | 85.7 | 21 | 100 |
CT | 15 | 15 | 100 | 15 | 100 | 13 | 86.7 | 15 | 100 |
AML: Amoxicillin; AMP: Ampicillin; K: Kanamycin; NV: Novobiocin; My: Lincomycin; E: Erythromycin; OL: Oleandomycin; SP:Spiramycin: NA: Nalidixic acid; OA: Oxolinic Acid; UB: Flumequine; RL: Sulphamethoxazole; DO: Doxycycline; OT: Oxytetracycline; TE: Tetracycline; C: Chloramphenicol; FFC: Florfenicol; F:Nitrofurantoin; FR: Furazolidone; FOS: Fosfomycin; CT: Colistin Sulphate; TNo: Number of isolates resistant to particular antibiotic; No: Number of isolates resist to heavy metal and antibiotic; %: Percentage of isolate resistance to antibiotic and heavy metal.